Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
594.66B
Market cap594.66B
Price-Earnings ratio
29.35
Price-Earnings ratio29.35
Dividend yield
2.06%
Dividend yield2.06%
Average volume
7.27M
Average volume7.27M
High today
$256.83
High today$256.83
Low today
$246.00
Low today$246.00
Open price
$250.00
Open price$250.00
Volume
10.55M
Volume10.55M
52 Week high
$269.43
52 Week high$269.43
52 Week low
$154.80
52 Week low$154.80

Stock Snapshot

With a market cap of 594.66B, Johnson & Johnson(JNJ) trades at $247.76. The stock has a price-to-earnings ratio of 29.35 and currently yields dividends of 2.06%.

As of 2026-07-15, Johnson & Johnson(JNJ) stock has fluctuated between $246.00 and $256.83. The current price stands at $247.76, placing the stock +0.7% above today's low and -3.5% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 10.55M, compared to an average daily volume of 7.27M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.

JNJ News

TipRanks 25m
Johnson & Johnson Earnings Call Signals Confident Growth

Johnson & Johnson ((JNJ)) has held its Q2 earnings call. Read on for the main highlights of the call. TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has enter...

Nasdaq 3h
Stock Market Today, July 15: Markets Rise on Cooler Inflation and Strong Earnings Start

The Nasdaq Composite (NASDAQINDEX:^IXIC) rose 0.62% to 26,269 as technology buyers focused on artificial intelligence (AI) infrastructure, the S&P 500 (SNPINDEX...

Stock Market Today, July 15: Markets Rise on Cooler Inflation and Strong Earnings Start
TipRanks 5h
JNJ: Strong Innovative Medicine Drives Guidance Raise but Mixed MedTech Keeps Risk/Reward Balanced, Supporting Hold Rating

In a report released today, Rick Wise from Stifel Nicolaus maintained a Hold rating on Johnson & Johnson, with a price target of $260.00. TipRanks has entered...

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

CNBC 5h
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways - CNBC

...

J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways - CNBC
TipRanks 5h
Johnson & Johnson price target raised to $260 from $250 at Stifel

Stifel analyst Rick Wise raised the firm’s price target on Johnson & Johnson to $260 from $250 and keeps a Hold rating on the shares. The company delivered “sol...

24/7 Wall St. 7h
Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price By Vandita Jadeja Published Jul 15, 1:29PM EDT Quick Read JNJ earns a B...

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price
24/7 Wall St. 8h
Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King

This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants...

Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King
Nasdaq 10h
J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised

Johnson & Johnson’s JNJ second-quarter 2026 earnings came in at $2.90 per share, which beat the Zacks Consensus Estimate of $2.84. Earnings rose 4.7% from the y...

J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised
24/7 Wall St. 10h
Walmart vs Johnson & Johnson: Two Defensive Plays, Diverging Strategies and One Winner

Walmart vs Johnson & Johnson: Two Defensive Plays, Diverging Strategies and One Winner By Vandita Jadeja Published Jul 15, 10:00AM EDT Quick Read Walmart's eC...

Walmart vs Johnson & Johnson: Two Defensive Plays, Diverging Strategies and One Winner
Benzinga 11h
Johnson & Johnson Finds Growth Beyond Legacy Drugs, Lifts 2026 Outlook

Adjusted earnings rose 4.7% year over year to $2.90 per share, beating the analyst consensus estimate of $2.85. Sales increased 6.6% to $25.31 billion, ahead of...

Johnson & Johnson Finds Growth Beyond Legacy Drugs, Lifts 2026 Outlook

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.